Ozanex Cream
Ozenoxacin topical
10mg/g
FERRER INTERNACIONAL S.A
| Pack size | 1 Tube (10g) |
|---|---|
| Dispensing mode | POM |
| Source | SPAIN |
| Agent | GREEN PHARMA STORES |
| Retail Price | 76.00 AED |
Indications
Ozanex Cream is used for:
Impetigo
Adult Dose
Impetigo
Indicated for impetigo due to Staphylococcus aureus (S. aureus) or Streptococcus pyogenes (S. pyogenes) in adults and children aged >2 months
Apply a thin layer topically to affected area q12hr for 5 days
Affected area may be up to 100 cm² in adults and adolescents aged >12 years
Child Dose
Impetigo
Indicated for impetigo due to Staphylococcus aureus (S. aureus) or Streptococcus pyogenes (S. pyogenes) in adult and children ?2 months
See also Administration
<2 months: Safety and efficacy not established
2 months to <12 years
Apply a thin layer topically to affected area q12hr for 5 days
Affected area may be up to 2% of the total body surface area and not exceeding 100 cm²
>12 years
Apply a thin layer topically to affected area q12hr for 5 days
Affected area may be up to 100 cm² in adults and adolescents aged >12 years
Renal Dose
Administration
Topical use only
Apply a thin layer topically to affected area
Wash hands prior to application if the hands are not the area for treatment
Do not swallow ozenoxacin or use it in the eyes, mouth, lips, inside the nose, or inside the female genital area
Treated area may be covered by a sterile bandage or gauze dressing
Contra Indications
Precautions
Prolonged use of ozenoxacin may result in overgrowth of nonsusceptible bacteria and fungi; if such infections occur, discontinue use and institute alternative therapy
Antagonism interactions with ozenoxacin were observed with ciprofloxacin against S. aureus
Pregnancy-Lactation
Pregnancy
Data are not available on the use of ozenoxacin in pregnant women
Systemic absorption of ozenoxacin in humans is negligible following topical administration of ozenoxacin; owing to the negligible systemic exposure, it is not expected that maternal use of ozenoxacin will result in fetal exposure to the drug
Lactation
No data are available regarding the presence of ozenoxacin in human milk, and the effects of ozenoxacin on the breastfed infant or on milk production
Breastfeeding is not expected to result in exposure of the child to ozenoxacin due to the negligible systemic absorption of ozenoxacin in humans following topical administration of ozenoxacin
Interactions
Adverse Effects
Side effects of Ozenoxacin topical :
Frequency Not Defined
Rosacea
Seborrheic dermatitis
Mechanism of Action
Quinolone antimicrobial drug; it inhibits bacterial DNA replication enzymes, DNA gyrase A, and topoisomerase IV
Ozenoxacin has been shown to be bactericidal against S. aureus (including methicillin-resistant isolates) and S. pyogenes organisms
Note
Ozanex 10mg/g Cream manufactured by FERRER INTERNACIONAL S.A. Its generic name is Ozenoxacin topical. Ozanex is availble in United Arab Emirates.
Farmaco UAE drug index information on Ozanex Cream is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.